Back to Search Start Over

Interferon-αn1, treatment benefits most patients with chronic myeloid leukaemia

Authors :
N.C. Allan
Source :
Biomedicine & Pharmacotherapy. 50:93-94
Publication Year :
1996
Publisher :
Elsevier BV, 1996.

Subjects

Subjects :
Pharmacology
business.industry
Interferon
Immunology
Medicine
General Medicine
business
Chronic myeloid leukaemia
medicine.drug

Details

ISSN :
07533322
Volume :
50
Database :
OpenAIRE
Journal :
Biomedicine & Pharmacotherapy
Accession number :
edsair.doi...........ab7cf9a5a531b89da1d85af704e919fe

Tools

Authors Abstract Subjects Details